128 related articles for article (PubMed ID: 2979706)
1. Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo.
Ringe D; Turesky RJ; Skipper PL; Tannenbaum SR
Chem Res Toxicol; 1988; 1(1):22-4. PubMed ID: 2979706
[No Abstract] [Full Text] [Related]
2. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
3. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
4. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
5. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
[TBL] [Abstract][Full Text] [Related]
6. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin.
Green LC; Skipper PL; Turesky RJ; Bryant MS; Tannenbaum SR
Cancer Res; 1984 Oct; 44(10):4254-9. PubMed ID: 6467185
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
8. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
Seyler TH; Reyes LR; Bernert JT
J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
[TBL] [Abstract][Full Text] [Related]
10. Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation.
Skipper PL; Bryant MS; Tannenbaum SR; Groopman JD
J Occup Med; 1986 Aug; 28(8):643-6. PubMed ID: 3746485
[TBL] [Abstract][Full Text] [Related]
11. Blood proteins as carcinogen dosimeters.
Tannenbaum SR; Skipper PL
Basic Life Sci; 1986; 38():473-8. PubMed ID: 3741339
[No Abstract] [Full Text] [Related]
12. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of multivitamin on the formation of hemoglobin adduct in 4-aminobiphenyl-treated rat.
Qin T; Xu XB; Zhao LX; Jin ZL
Bull Environ Contam Toxicol; 2001 Nov; 67(5):649-56. PubMed ID: 11911633
[No Abstract] [Full Text] [Related]
14. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
15. A new relaxed state in horse methemoglobin characterized by crystallographic studies.
Sankaranarayanan R; Biswal BK; Vijayan M
Proteins; 2005 Aug; 60(3):547-51. PubMed ID: 15887226
[TBL] [Abstract][Full Text] [Related]
16. Effects of lead on 4-aminobiphenyl pharmacokinetics in liver, kidney, spleen, testes, heart, lung and hemoglobin adduct for rat model.
Chen HM; Qin T; Zhao LX; Xu XB
Ecotoxicology; 2002 Aug; 11(4):255-64. PubMed ID: 12211698
[TBL] [Abstract][Full Text] [Related]
17. Identification of the major serum albumin adduct formed by 4-aminobiphenyl in vivo in rats.
Skipper PL; Obiedzinski MW; Tannenbaum SR; Miller DW; Mitchum RK; Kadlubar FF
Cancer Res; 1985 Oct; 45(10):5122-7. PubMed ID: 4027989
[TBL] [Abstract][Full Text] [Related]
18. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
[TBL] [Abstract][Full Text] [Related]
19. Supramolecular iron porphyrin/cyclodextrin dimer complex that mimics the functions of hemoglobin and methemoglobin.
Watanabe K; Kitagishi H; Kano K
Angew Chem Int Ed Engl; 2013 Jul; 52(27):6894-7. PubMed ID: 23712820
[No Abstract] [Full Text] [Related]
20. Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans.
Ketelslegers HB; Godschalk RW; Eskens BJ; Dallinga JW; Gottschalk RW; van Schooten FJ; van Delft JH; Kleinjans JC
Mol Carcinog; 2009 Aug; 48(8):685-91. PubMed ID: 19274671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
